No new patients should start treatment with Lartruvo after study shows cancer medicine does not prolong life

View source ↗

Summary

EMA advises that no new patients should start treatment with Larotrectinib? wait: article states Lartruvo (avelumab? actually Lartruvo is olaratumab) after stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Lartruvo (olaratumab)